Literature DB >> 23373806

Postoperative ischemic changes following resection of newly diagnosed and recurrent gliomas and their clinical relevance.

Jens Gempt1, Annette Förschler, Niels Buchmann, Haiko Pape, Yu-Mi Ryang, Sandro M Krieg, Claus Zimmer, Bernhard Meyer, Florian Ringel.   

Abstract

OBJECT: The aim of surgical treatment of glioma is the complete resection of tumor tissue with preservation of neurological function. Inclusion of diffusion-weighted imaging (DWI) in the postoperative MRI protocol could improve the delineation of ischemia-associated postoperative neurological deficits. The present study aims to assess the incidence of infarctions following resection of newly diagnosed gliomas in comparison with recurrent gliomas and the influence on neurological function.
METHODS: Patients who underwent glioma resection for newly diagnosed or recurrent gliomas had early postoperative MRI, including DWI and apparent diffusion coefficient (ADC) maps. Postoperative areas of restricted diffusion were classified as arterial territorial infarctions, terminal branch infarctions, or venous infarctions. Tumor entity, location, and neurological function were recorded.
RESULTS: New postoperative ischemic lesions were identified in 26 (31%) of 84 patients with newly diagnosed gliomas and 20 (80%) of 25 patients with recurrent gliomas (p < 0.01). New permanent and transient neurological deficits were more frequent in patients with recurrent gliomas than in patients with newly diagnosed tumors. Patients with neurological deficits had a significantly higher rate of ischemic lesions.
CONCLUSIONS: Postoperative infarctions occur frequently in patients with newly diagnosed and recurrent gliomas and do have an impact on postoperative neurological function. In this patient cohort there was a higher risk for ischemic lesions and for deterioration of neurological function after resection of recurrent tumors. Radiogenic and postoperative tissue changes could contribute to the higher risk of an ischemic infarction in patients with recurrent tumors.

Entities:  

Mesh:

Year:  2013        PMID: 23373806     DOI: 10.3171/2012.12.JNS12125

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  24 in total

Review 1.  The role of surgery in grade II/III oligodendroglial tumors.

Authors:  Niklas Thon; Friedrich-Wilhelm Kreth; Joerg-Christian Tonn
Journal:  CNS Oncol       Date:  2015-10-19

Review 2.  Conventional and advanced imaging throughout the cycle of care of gliomas.

Authors:  Gilles Reuter; Martin Moïse; Wolfgang Roll; Didier Martin; Arnaud Lombard; Félix Scholtes; Walter Stummer; Eric Suero Molina
Journal:  Neurosurg Rev       Date:  2021-01-07       Impact factor: 3.042

3.  Surgical complications following malignant brain tumor surgery: An analysis of 2002-2011 data.

Authors:  Rafael De la Garza-Ramos; Panagiotis Kerezoudis; Rafael J Tamargo; Henry Brem; Judy Huang; Mohamad Bydon
Journal:  Clin Neurol Neurosurg       Date:  2015-11-12       Impact factor: 1.876

4.  Pseudo-continuous arterial spin labelling shows high diagnostic performance in the detection of postoperative residual lesion in hyper-vascularised adult brain tumours.

Authors:  Clara Cohen; Bruno Law-Ye; Didier Dormont; Delphine Leclercq; Laurent Capelle; Marc Sanson; Damien Galanaud; Nadya Pyatigorskaya
Journal:  Eur Radiol       Date:  2020-01-21       Impact factor: 5.315

5.  Surgically acquired deficits and diffusion weighted MRI changes after glioma resection--a matched case-control study with blinded neuroradiological assessment.

Authors:  Asgeir S Jakola; Erik M Berntsen; Pål Christensen; Sasha Gulati; Geirmund Unsgård; Kjell A Kvistad; Ole Solheim
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

6.  Safe Brain Tumor Resection Does not Depend on Surgery Alone - Role of Hemodynamics.

Authors:  Stefanie Bette; Benedikt Wiestler; Felicitas Wiedenmann; Johannes Kaesmacher; Martin Bretschneider; Melanie Barz; Thomas Huber; Yu-Mi Ryang; Eberhard Kochs; Claus Zimmer; Bernhard Meyer; Tobias Boeckh-Behrens; Jan S Kirschke; Jens Gempt
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

7.  Impact of ischemic preconditioning on surgical treatment of brain tumors: a single-center, randomized, double-blind, controlled trial.

Authors:  Arthur H A Sales; Melanie Barz; Stefanie Bette; Benedikt Wiestler; Yu-Mi Ryang; Bernhard Meyer; Martin Bretschneider; Florian Ringel; Jens Gempt
Journal:  BMC Med       Date:  2017-07-25       Impact factor: 8.775

8.  A Multilevel Analysis of Surgical Category and Individual Patient-Level Risk Factors for Postoperative Stroke.

Authors:  Benjamin R Kummer; Rebecca Hazan; Alexander E Merkler; Hooman Kamel; Joshua Z Willey; William Middlesworth; Shadi Yaghi; Randolph S Marshall; Mitchell S V Elkind; Amelia K Boehme
Journal:  Neurohospitalist       Date:  2019-05-07

Review 9.  Glioma Recurrence following Surgery: Peritumoral or Perilesional?

Authors:  Boudewijn van der Sanden; David Ratel; François Berger; Didier Wion
Journal:  Front Neurol       Date:  2016-03-31       Impact factor: 4.003

10.  Infarct volume after glioblastoma surgery as an independent prognostic factor.

Authors:  Stefanie Bette; Benedikt Wiestler; Johannes Kaesmacher; Thomas Huber; Julia Gerhardt; Melanie Barz; Claire Delbridge; Yu-Mi Ryang; Florian Ringel; Claus Zimmer; Bernhard Meyer; Tobias Boeckh-Behrens; Jan S Kirschke; Jens Gempt
Journal:  Oncotarget       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.